Labex Canada Inc.

Labex Canada Inc. was established as a Laboratory Supplier Company, and federally registered in 2011 in Halifax, Nova Scotia, Canada. In 2014, a new facility was opened in Newmarket, Ontario and in 2015 the company has been completely moved to Newmarket. In 2020, we started to focus on helping the world communities with the COVID-19 pandemic and developed different diagnostic kits for diagnosis and management of the disease. In 2021 we got MDASP/ISO 13485:2016 certification. In 2022, we started to introduce our IHC primary antibodies and FISH probes and initiated production of our Fully automatic IHC Stainer. IHC and FISH are 2 golden standards for Cancer diagnostics. LC-AS20, a Stainer with the capacity of 20 slides per run was introduced first and in 2023, a higher throughput IHC stainer with the capacity of 88 slides per run, (LC-AS88) followed. 40 of our tumor markers (primary antibodies) and 3 FISH probes got Health Canada certifications, and both of the stainers and FISH hybridizer have been registered with Health Canada. In early 2024 Labex Canada moved to the new, larger premises to be able to better fulfil company’s production and sales activities. We are eager to continue to add more products and services to our portfolio in order to serve our customers more and better.